[1]关 旭,田 桦,卓 越,等.不同疗程布拉氏酵母菌对四联疗法根除Hp的影响[J].医学信息,2020,33(05):144-145.[doi:10.3969/j.issn.1006-1959.2020.05.046]
　GUAN Xu,TIAN Hua,ZHUO Yue,et al.Effects of Different Courses of Candida Bratella on the Eradication of Hp by Quadruple Therapy[J].Medical Information,2020,33(05):144-145.[doi:10.3969/j.issn.1006-1959.2020.05.046]
点击复制

不同疗程布拉氏酵母菌对四联疗法根除Hp的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年05期
页码:
144-145
栏目:
药物与临床
出版日期:
2020-03-01

文章信息/Info

Title:
Effects of Different Courses of Candida Bratella on the Eradication of Hp by Quadruple Therapy
文章编号:
1006-1959（2020）05-0144-02
作者:
关 旭; 田 桦; 卓 越; 等
（佳木斯大学附属第一医院，黑龙江 佳木斯 154003）
Author(s):
GUAN Xu; TIAN Hua; ZHUO Yue; et al
(The First Affiliated Hospital of Jiamusi University,Jiamusi 154003,Heilongjiang,China)
关键词:
幽门螺旋杆菌; 四联疗法; 根除率
Keywords:
Helicobacter pylori; Quadruple therapy; Eradication rate
分类号:
R453.2
DOI:
10.3969/j.issn.1006-1959.2020.05.046
文献标志码:
A
摘要:
目的 观察不同疗程布拉氏酵母菌对四联疗法根除Hp的影响。方法 选择2018年12月~2019年10月佳木斯大学一附院消化内科门诊收治的幽门螺杆菌（Hp）阳性患者160例作为研究对象，随机分为A、B、C、D四组，各40例。A组口服丽珠维三联+雷贝拉唑，B、C和D组在A组基础上分别加用2、4、6周布拉氏酵母菌。比较各组Hp根除率及不良反应发生率。结果 A、B、C、D组Hp根除率分别为50.00%、76.92%、76.32%、81.08%，组间比较，差异有统计学意义（P＜0.05）；其中B、C、D组Hp根除率高于A组，差异有统计学意义（P＜0.05）；B、C、D组Hp根除率比较，差异无统计学意义（P＞0.05）；A、B、C、D组不良反应发生率分别为42.10%、7.50%、5.13%、5.26%，组间比较，差异有统计学意义（P＜0.05）；其中B、C、D组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 不同疗程的布拉氏酵母菌联合四联疗法均对Hp的根除有较好的效果，但延长布拉氏酵母菌疗程对Hp根除效果无明显提高作用。
Abstract:
Objective To observe the effect of different courses of yeast brasiella on the eradication of Hp by quadruple therapy.Methods From December 2018 to October 2019, 160 Hp-positive patients admitted to the Department of Gastroenterology of the first affiliated hospital of Jiamusi University were selected as the research objects, and they were randomly divided into four groups, A,B,C, and D,with 40 cases each. Group A was orally administered with Lizhuweitriple + rabeprazole, Groups B,C, and D were supplemented with Candida bratellafor 2,4, and 6 weeks on the basis of group A, respectively. Compare the eradication rate of Hp and the incidence of adverse reactions in each group.Results The root exclusion rates of Hp in A,B,C and D groups were 50.00%,76.92%,76.32% and 81.08% respectively,the difference was statistically significant (P<0.05); the eradication rate of Hp in groups B,C, and D was higher than that in group A,the difference was statistically significant (P<0.05); there was no difference in Hp eradication rate in groups B,C, and D(P>0.05); the incidence of adverse reactions in groups A,B,C, and D were 42.10%,7.50%,5.13%, and 5.26%,the differences between groups were statistically significant (P<0.05); There was no significant difference in the incidence of adverse reactions between groups B,C, and D (P>0.05).Conclusion Different courses of Candida bratella combined with quadruple therapy had good effect on Hp eradication, but prolonged course of Candida bratella had no significant effect on Hp eradication.

参考文献/References:

[1]Lau CS,Ward A,Chamberlain RS.Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori：a meta-analysis[J].In fect Drug Resist,2016(9):275-289.[2]楚杰,王凤山,张大伟.布拉酵母菌的生物学作用及防治疾病应用研究进展[J].药物生物技术,2006(1):71-73.[3]周雪亮,周渊,朱强,等.幽门螺旋杆菌的研究进展[J].中国继续医学教育,2018,10(33):101-104.[4]韩一凡,于新娟,王莉莉,等．中国Hp耐药情况研究[J].胃肠病学和肝病学杂志,2017,26(6):664-669．[5]孙楠.185例抗生素类药品不良反应报告分析[J].临床合理用药杂志,2018,11(25):120-122.

相似文献/References:

[1]邱君旗.幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良患者疗效分析[J].医学信息,2018,31(04):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
　QIU Jun-qi.Efficacy of Helicobacter Pylori Eradication Therapy in Patients with HP Positive Functional Dyspepsia[J].Medical Information,2018,31(05):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
[2]邱梦君,郑国荣.大黄、黄连、黄芩联合三联序贯治疗Hp感染的疗效分析[J].医学信息,2018,31(06):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
　QIU Meng-jun,ZHENG Guo-rong.Curative Effect Analysis of Sequential Treatment of Hp Infection by Rhubarb,Coptis Chinensis and Radix Scutellariae[J].Medical Information,2018,31(05):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
[3]夏 铭,张正坤,曾海龙,等.四种疗法治疗幽门螺杆菌阳性消化性溃疡疗效分析[J].医学信息,2018,31(11):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
　XIA Ming,ZHANG Zheng-kun,ZENG Hai-long,et al.Therapeutic Effect of Four Kinds of Therapy on Helicobacter Pylori Positive Peptic Ulcer[J].Medical Information,2018,31(05):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
[4]陈 鹏,吴 楠,葛俊君,等.地衣芽胞杆菌联合幽门螺旋杆菌补救疗法的临床观察[J].医学信息,2018,31(23):114.[doi:10.3969/j.issn.1006-1959.2018.23.031]
　CHEN Peng,WU Nan,GE Jun-jun,et al.Clinical Observation of Bacillus Licheniformis Combined with H.pylori Salvage Therapy[J].Medical Information,2018,31(05):114.[doi:10.3969/j.issn.1006-1959.2018.23.031]
[5]罗小洋,刘戈云,熊 欢,等.老年性胃溃疡相关因素临床研究[J].医学信息,2022,35(18):93.[doi:10.3969/j.issn.1006-1959.2022.18.024]
　LUO Xiao-yang,LIU Ge-yun,XIONG Huan,et al.Clinical Study on Related Factors of Senile Gastric Ulcer[J].Medical Information,2022,35(05):93.[doi:10.3969/j.issn.1006-1959.2022.18.024]
[6]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
　WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Medical Information,2022,35(05):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
[7]郭月欢,甘惠中.幽门螺旋杆菌感染与非酒精性脂肪肝的相关性研究[J].医学信息,2022,35(08):89.[doi:10.3969/j.issn.1006-1959.2022.08.021]
　GUO Yue-huan,GAN Hui-zhong.Correlation Between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease[J].Medical Information,2022,35(05):89.[doi:10.3969/j.issn.1006-1959.2022.08.021]
[8]陈淑平,张 苗,王丽芳.蒲公英联合四联方案治疗脾胃湿热型幽门螺旋杆菌感染相关性胃炎的疗效[J].医学信息,2023,36(13):107.[doi:10.3969/j.issn.1006-1959.2023.13.021]
　CHEN Shu-ping,ZHANG Miao,WANG Li-fang.Efficacy of Dandelion Combined with Quadruple Regimen in the Treatment of Helicobacter Pylori Infection-related Gastritis of Spleen-stomach Damp-heat Type[J].Medical Information,2023,36(05):107.[doi:10.3969/j.issn.1006-1959.2023.13.021]
[9]闫静静,韩 怡.幽门螺旋杆菌感染与非酒精性脂肪性肝病的相关性研究[J].医学信息,2023,36(18):114.[doi:10.3969/j.issn.1006-1959.2023.18.021]
　YAN Jing-jing,HAN Yi.Correlation Analysis Between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease[J].Medical Information,2023,36(05):114.[doi:10.3969/j.issn.1006-1959.2023.18.021]
[10]刘克学.铝碳酸镁联合兰索拉唑治疗幽门螺旋杆菌相关性胃溃疡的临床疗效及安全性[J].医学信息,2023,36(18):140.[doi:10.3969/j.issn.1006-1959.2023.18.027]
　LIU Ke-xue.Clinical Efficacy and Safety of Hydrotalcite Combined with Lansoprazole in the Treatment of Helicobacter Pylori-associated Gastric Ulcer[J].Medical Information,2023,36(05):140.[doi:10.3969/j.issn.1006-1959.2023.18.027]
[11]侯拂晓.四联疗法治疗幽门螺旋杆菌相关性十二指肠球炎疗效分析[J].医学信息,2018,31(17):135.[doi:10.3969/j.issn.1006-1959.2018.17.042]
　HOU Fu-xiao.Therapeutic Effect of Quadruple Therapy on Helicobacter pylori Associated Duodenal Inflammation[J].Medical Information,2018,31(05):135.[doi:10.3969/j.issn.1006-1959.2018.17.042]
[12]谢迎新.复方嗜酸乳杆菌联合常规四联疗法治疗幽门螺旋杆菌感染消化性溃疡的疗效[J].医学信息,2020,33(02):138.[doi:10.3969/j.issn.1006-1959.2020.02.040]
　XIE Ying-xin.Effect of Compound Lactobacillus Acidophilus Combined with Conventional Quadruple Therapy in the Treatment of Peptic Ulcer Caused by Helicobacter Pylori Infection[J].Medical Information,2020,33(05):138.[doi:10.3969/j.issn.1006-1959.2020.02.040]

更新日期/Last Update: 2020-03-01